메뉴 건너뛰기




Volumn 4, Issue 5, 2013, Pages 810-816

Discovery of novel pyridazinylthioacetamides as potent HIV-1 NNRTIs using a structure-based bioisosterism approach

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (NAPHTHALEN 1 YL)PYRIDAZIN 3 YLTHIO] N ARYLACETAMIDE DERIVATIVE; ARYLAZOLYLTHIOACETANILIDE DERIVATIVE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PYRIDAZINYLTHIOACETAMIDE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; ZALCITABINE;

EID: 84877282540     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c3md00028a     Document Type: Article
Times cited : (10)

References (38)
  • 1
    • 84874114410 scopus 로고    scopus 로고
    • Antivirals: Past, present and future
    • E. De Clercq Antivirals: past, present and future Biochem. Pharmacol. 2013 85 727 744
    • (2013) Biochem. Pharmacol. , vol.85 , pp. 727-744
    • De Clercq, E.1
  • 2
    • 84867403312 scopus 로고    scopus 로고
    • Human viral diseases: What is next for antiviral drug discovery?
    • E. De Clercq Human viral diseases: what is next for antiviral drug discovery? Curr. Opin. Virol. 2012 2 572 579
    • (2012) Curr. Opin. Virol. , vol.2 , pp. 572-579
    • De Clercq, E.1
  • 3
    • 84870202766 scopus 로고    scopus 로고
    • New therapeutic landscape of NNRTIs for treatment of HIV: A look at recent data
    • D. Jayaweera P. Dilanchian New therapeutic landscape of NNRTIs for treatment of HIV: a look at recent data Expert Opin. Pharmacother. 2012 13 2601 2612
    • (2012) Expert Opin. Pharmacother. , vol.13 , pp. 2601-2612
    • Jayaweera, D.1    Dilanchian, P.2
  • 4
    • 70349395798 scopus 로고    scopus 로고
    • Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006-2008 update
    • P. Zhan X. Liu Z. Li Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006-2008 update Curr. Med. Chem. 2009 16 2876 2889
    • (2009) Curr. Med. Chem. , vol.16 , pp. 2876-2889
    • Zhan, P.1    Liu, X.2    Li, Z.3
  • 6
    • 84876852661 scopus 로고    scopus 로고
    • Structural diversity, pharmacophore similarity, and implications for drug design
    • 10.1002/med.20241
    • P. Zhan X. Chen D. Li Z. Fang E. De Clercq X. Liu Structural diversity, pharmacophore similarity, and implications for drug design Med. Res. Rev. 2011 10.1002/med.20241
    • (2011) Med. Res. Rev.
    • Zhan, P.1    Chen, X.2    Li, D.3    Fang, Z.4    De Clercq, E.5    Liu, X.6
  • 7
    • 79955104761 scopus 로고    scopus 로고
    • Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: A patent review (2005-2010)
    • P. Zhan X. Liu Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005-2010) Expert Opin. Ther. Pat. 2011 5 717 796
    • (2011) Expert Opin. Ther. Pat. , vol.5 , pp. 717-796
    • Zhan, P.1    Liu, X.2
  • 8
    • 68149109726 scopus 로고    scopus 로고
    • Sulfanyltriazole/tetrazoles: A promising class of HIV-1 NNRTIs
    • P. Zhan Z. Li X. Liu E. De Clercq Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs Mini-Rev. Med. Chem. 2009 9 1014 1023
    • (2009) Mini-Rev. Med. Chem. , vol.9 , pp. 1014-1023
    • Zhan, P.1    Li, Z.2    Liu, X.3    De Clercq, E.4
  • 9
    • 33745727133 scopus 로고    scopus 로고
    • Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors
    • Z. Wang B. Wu K. L. Kuhen B. Bursulaya T. N. Nguyen D. G. Nguyen Y. He Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors Bioorg. Med. Chem. Lett. 2006 16 4174 4177
    • (2006) Bioorg. Med. Chem. Lett. , vol.16 , pp. 4174-4177
    • Wang, Z.1    Wu, B.2    Kuhen, K.L.3    Bursulaya, B.4    Nguyen, T.N.5    Nguyen, D.G.6    He, Y.7
  • 14
    • 59649115687 scopus 로고    scopus 로고
    • Investigation on the role of the tetrazole in the binding of thiotetrazolylacetanilides with HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases
    • A. Gagnon S. Landry R. Coulombe A. Jakalian I. Guse B. Thavonekham P. R. Bonneau C. Yoakim B. Simoneau Investigation on the role of the tetrazole in the binding of thiotetrazolylacetanilides with HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases Bioorg. Med. Chem. Lett. 2009 19 1199 1205
    • (2009) Bioorg. Med. Chem. Lett. , vol.19 , pp. 1199-1205
    • Gagnon, A.1    Landry, S.2    Coulombe, R.3    Jakalian, A.4    Guse, I.5    Thavonekham, B.6    Bonneau, P.R.7    Yoakim, C.8    Simoneau, B.9
  • 16
    • 84860289205 scopus 로고    scopus 로고
    • Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: Lessons from the development of seven representative paradigms
    • D. Li P. Zhan E. De Clercq X. Liu Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms J. Med. Chem. 2012 55 3595 3613
    • (2012) J. Med. Chem. , vol.55 , pp. 3595-3613
    • Li, D.1    Zhan, P.2    De Clercq, E.3    Liu, X.4
  • 17
    • 53349162138 scopus 로고    scopus 로고
    • 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors
    • P. Zhan X. Liu Y. Cao Y. Wang C. Pannecouque E. De Clercq 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors Bioorg. Med. Chem. Lett. 2008 18 5368 5371
    • (2008) Bioorg. Med. Chem. Lett. , vol.18 , pp. 5368-5371
    • Zhan, P.1    Liu, X.2    Cao, Y.3    Wang, Y.4    Pannecouque, C.5    De Clercq, E.6
  • 18
    • 68149145657 scopus 로고    scopus 로고
    • Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies
    • P. Zhan X. Liu Z. Li Z. Fang Z. Li D. Wang C. Pannecouque E. De Clercq Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: synthesis and preliminary SAR studies Bioorg. Med. Chem. 2009 17 5920 5927
    • (2009) Bioorg. Med. Chem. , vol.17 , pp. 5920-5927
    • Zhan, P.1    Liu, X.2    Li, Z.3    Fang, Z.4    Li, Z.5    Wang, D.6    Pannecouque, C.7    De Clercq, E.8
  • 19
    • 70349774254 scopus 로고    scopus 로고
    • Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2, 3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
    • P. Zhan X. Liu Z. Fang Z. Li C. Pannecouque E. De Clercq Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5- ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors Eur. J. Med. Chem. 2009 44 4648 4653
    • (2009) Eur. J. Med. Chem. , vol.44 , pp. 4648-4653
    • Zhan, P.1    Liu, X.2    Fang, Z.3    Li, Z.4    Pannecouque, C.5    De Clercq, E.6
  • 20
    • 77954695191 scopus 로고    scopus 로고
    • 1,2,3-Thiadiazole thioacetanilides. Part 2: Synthesis and biological evaluation of a new series of 2-{[4-(3,4-dichlorophenyl)-1,2,3-thiadiazol-5-yl] sulfanyl}acetanilides as HIV-1 inhibitors
    • P. Zhan X. Liu Z. Li Z. Fang C. Pannecouque E. De Clercq 1,2,3-Thiadiazole thioacetanilides. Part 2: synthesis and biological evaluation of a new series of 2-{[4-(3,4-dichlorophenyl)-1,2,3-thiadiazol-5-yl]sulfanyl} acetanilides as HIV-1 inhibitors Chem. Biodiversity 2010 7 1717 1727
    • (2010) Chem. Biodiversity , vol.7 , pp. 1717-1727
    • Zhan, P.1    Liu, X.2    Li, Z.3    Fang, Z.4    Pannecouque, C.5    De Clercq, E.6
  • 21
    • 68149089670 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
    • P. Zhan X. Liu J. Zhu Z. Fang Z. Li C. Pannecouque E. De Clercq Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors Bioorg. Med. Chem. 2009 17 5775 5781
    • (2009) Bioorg. Med. Chem. , vol.17 , pp. 5775-5781
    • Zhan, P.1    Liu, X.2    Zhu, J.3    Fang, Z.4    Li, Z.5    Pannecouque, C.6    De Clercq, E.7
  • 22
    • 68649109125 scopus 로고    scopus 로고
    • 1,2,3-Selenadiazole thioacetanilides: Synthesis and anti-HIV activity evaluation
    • P. Zhan X. Liu Z. Fang C. Pannecouque E. De Clercq 1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation Bioorg. Med. Chem. 2009 17 6374 6379
    • (2009) Bioorg. Med. Chem. , vol.17 , pp. 6374-6379
    • Zhan, P.1    Liu, X.2    Fang, Z.3    Pannecouque, C.4    De Clercq, E.5
  • 23
    • 77956478098 scopus 로고    scopus 로고
    • Synthesis and anti-HIV activity evaluation of novel N′-arylidene-2- [1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio] acetohy drazides
    • P. Zhan H. Liu X. Liu Y. Wang C. Pannecouque M. Witvrouw E. De Clercq Synthesis and anti-HIV activity evaluation of novel N′-arylidene-2-[1- (naphthalen-1-yl)-1H-tetrazol-5-ylthio] acetohy drazides Med. Chem. Res. 2009 19 652 663
    • (2009) Med. Chem. Res. , vol.19 , pp. 652-663
    • Zhan, P.1    Liu, H.2    Liu, X.3    Wang, Y.4    Pannecouque, C.5    Witvrouw, M.6    De Clercq, E.7
  • 24
    • 80053197763 scopus 로고    scopus 로고
    • Arylazolylthioacetanilide. Part 8*: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3- ylthio)-N-arylacetamides as potent HIV-1 inhibitors
    • P. Zhan X. Chen X. Li D. Li Y. Tian W. Chen C. Pannecouque E. De Clercq X. Liu Arylazolylthioacetanilide. Part 8*: design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3- ylthio)-N-arylacetamides as potent HIV-1 inhibitors Eur. J. Med. Chem. 2011 46 5039 5045
    • (2011) Eur. J. Med. Chem. , vol.46 , pp. 5039-5045
    • Zhan, P.1    Chen, X.2    Li, X.3    Li, D.4    Tian, Y.5    Chen, W.6    Pannecouque, C.7    De Clercq, E.8    Liu, X.9
  • 25
  • 26
    • 7744243992 scopus 로고    scopus 로고
    • Bioisosterism: A rational approach in drug design
    • G. A. Patani E. J. LaVoie Bioisosterism: a rational approach in drug design Chem. Rev. 1996 96 3147 3176
    • (1996) Chem. Rev. , vol.96 , pp. 3147-3176
    • Patani, G.A.1    Lavoie, E.J.2
  • 27
    • 0034924558 scopus 로고    scopus 로고
    • The use of bioisosteric groups in lead optimization
    • P. H. Olesen The use of bioisosteric groups in lead optimization Curr. Opin. Drug Discovery Dev. 2001 4 471 478
    • (2001) Curr. Opin. Drug Discovery Dev. , vol.4 , pp. 471-478
    • Olesen, P.H.1
  • 28
    • 11844255399 scopus 로고    scopus 로고
    • Bioisosterism: A useful strategy for molecular modification and drug design
    • L. M. Lima E. J. Barreiro Bioisosterism: a useful strategy for molecular modification and drug design Curr. Med. Chem. 2005 12 23 49
    • (2005) Curr. Med. Chem. , vol.12 , pp. 23-49
    • Lima, L.M.1    Barreiro, E.J.2
  • 29
    • 67349142564 scopus 로고    scopus 로고
    • Medicinal chemistry strategies in follow-on drug discovery
    • H. Zhao Z. Guo Medicinal chemistry strategies in follow-on drug discovery Drug Discovery Today 2009 14 516 522
    • (2009) Drug Discovery Today , vol.14 , pp. 516-522
    • Zhao, H.1    Guo, Z.2
  • 31
    • 33847664739 scopus 로고    scopus 로고
    • N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro) -5′-N-ethylcarboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor
    • P. G. Baraldi D. Preti M. A. Tabrizi F. Fruttarolo G. Saponaro S. Baraldi R. Romagnoli A. R. Moorman S. Gessi K. Varani P. A. Borea N(6)-[(hetero)aryl/ (cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5′-N-ethylcarboxamido- adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor Bioorg. Med. Chem. 2007 15 2514 2527
    • (2007) Bioorg. Med. Chem. , vol.15 , pp. 2514-2527
    • Baraldi, P.G.1    Preti, D.2    Tabrizi, M.A.3    Fruttarolo, F.4    Saponaro, G.5    Baraldi, S.6    Romagnoli, R.7    Moorman, A.R.8    Gessi, S.9    Varani, K.10    Borea, P.A.11
  • 33
    • 0021237243 scopus 로고
    • Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
    • M. Popovic M. G. Sarngadharan E. Read R. C. Gallo Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS Science 1984 224 497 500
    • (1984) Science , vol.224 , pp. 497-500
    • Popovic, M.1    Sarngadharan, M.G.2    Read, E.3    Gallo, R.C.4
  • 36
    • 40749129190 scopus 로고    scopus 로고
    • Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: Revisited 20 years later
    • C. Pannecouque D. Daelemans E. De Clercq Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later Nat. Protocols 2008 3 427 434
    • (2008) Nat. Protocols , vol.3 , pp. 427-434
    • Pannecouque, C.1    Daelemans, D.2    De Clercq, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.